Department of Surgery, Austin Hospital, 145 Studley Rd, Heidelberg, VIC, 3084, Australia.
Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia.
Int J Colorectal Dis. 2021 Jun;36(6):1123-1132. doi: 10.1007/s00384-021-03851-8. Epub 2021 Jan 30.
There is increasing evidence that either a transanal stent (TAS) or rectal tube (RT) can decrease the risk of anastomotic leakage (AL) after anterior resection for rectal cancer, in which a diverting stoma may not be required.
The aim of this review was to investigate the efficacy and safety of RT/TAS in preventing AL after anterior resections.
An up-to-date systematic review was performed on the available literature between 2000 and 2020 on PubMed, EMBASE, Medline and Cochrane Library databases.
All studies reporting on anterior resections in adults, comparing transanal tube/stent versus non-tube/stent, were analysed.
The primary outcome was rates of AL, whereas secondary outcomes compared associated unplanned re-operation for AL and hospital length of stay (LOS).
Two randomized controlled trials and 13 observational studies were included, with 1714 patients receiving RT/TAS and 1741 patients without. There were 119 (7%) patients with AL in the RT/TAS group compared to 216 (12.3%) patients in the non-RT/TAS group (OR: 0.48, 95% CI: 0.38-0.62, p < 0.001). There were 47 (2.9%) patients with AL complications requiring surgery in the RT/TAS group compared to 132 (8%) patients in the non-RT/TAS group (OR: 0.29, 95% CI: 0.20-0.42, p < 0.001) and no significant difference identified with the standardized mean difference (SMD) favouring the RT/TAS group for hospital LOS (SMD: -0.23, 95% CI: -0.51 to 0.06, p = 0.115).
The use of RT/TAS post restorative anterior resection for rectal cancer should be considered, given the benefits shown from this meta-analysis.
越来越多的证据表明,经肛门支架(TAS)或直肠管(RT)可降低直肠癌前切除术后吻合口漏(AL)的风险,在这种情况下可能不需要转流造口术。
本综述旨在探讨 RT/TAS 预防前切除术后 AL 的疗效和安全性。
在 2000 年至 2020 年期间,对 PubMed、EMBASE、Medline 和 Cochrane Library 数据库中的可用文献进行了最新的系统综述。
分析了所有报告成人前切除术的研究,比较了经肛门管/支架与非管/支架。
主要结局是 AL 发生率,次要结局比较了因 AL 进行的计划外再次手术和住院时间(LOS)。
纳入了 2 项随机对照试验和 13 项观察性研究,共 1714 例患者接受 RT/TAS 治疗,1741 例患者未接受 RT/TAS 治疗。RT/TAS 组有 119 例(7%)患者发生 AL,非 RT/TAS 组有 216 例(12.3%)患者发生 AL(OR:0.48,95%CI:0.38-0.62,p<0.001)。RT/TAS 组有 47 例(2.9%)AL 并发症患者需要手术治疗,非 RT/TAS 组有 132 例(8%)患者需要手术治疗(OR:0.29,95%CI:0.20-0.42,p<0.001),两组患者住院 LOS 的标准化均数差(SMD)无显著差异,RT/TAS 组更有利(SMD:-0.23,95%CI:-0.51 至 0.06,p=0.115)。
鉴于本荟萃分析的结果,在进行直肠癌前切除术时,应考虑使用 RT/TAS。